Scheme Profile

HDFC Pharma and Healthcare Fund - Regular (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
1,896
Inception Date
04-10-2023
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 100
  • 52 Week High / Low ()
  • 17.862 (30-Jul-2025) / 14.57 (28-Feb-2025)
  • Incremental Investment ()
  • 100
  • NAV ()
  • 17.18 ( 0.05) ( 0.27 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Nikhil Mathur
  • Value of () 1,00,000 since inception
  • 1,71,810
  • Entry Load
  • Nil
  • Exit Load
  • In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.
  • Expense Ratio (%)
  • 2.08
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 57.26 times
  • Portfolio P/B
  • 8.25 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 34.40

Risk Factors

  • Jenson's Alpha
  • 20.31
  • Standard Deviation
  • 4.95
  • Beta
  • 0.78
  • Sharpe
  • 1.52
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.03

NAV Movement

AUM Growth ( Cr.)

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 30 Sep 2025 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 12,44,634
  • 10.47
  • Divis Laboratories Ltd
  • Equity
  • 2,58,490
  • 7.76
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 6,72,796
  • 6.93
  • Lupin Ltd
  • Equity
  • 6,78,274
  • 6.84
  • Alkem Laboratories Ltd
  • Equity
  • 2,07,521
  • 5.94

Sector Top 5 Holdings

  [ As on 30 Sep 2025 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,07,05,738
  • 77.91
  • Healthcare
  • 46,93,152
  • 22.09

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 0.55 -2.94 - 5.22 1,896.11
2024 49.92 34.92 10.35 8.12 1,577.12
2023 13.24 31.12 38.35 18.10 648.29

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Sep-2025 -0.37 -2.02 - 0 1,896.11
Jun-2025 7.55 7.66 - 0 1,786.18
Mar-2025 -6.82 -8.95 - 0 1,634.08
Dec-2024 5.39 1.62 - 0 1,577.12

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Close